SBIR/STTR Research Award

Reversible Reagents for Next Gen Biomolecule and Tissue Preservation

Award identifier d903bdf064738dd863e2e42047ae7f98d100f346824a3f1e8f70c64c1ab60113Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$225,000

Program and phase

SBIR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Cell Data Sciences, Inc
Proposal award date
2017-09-15
Contract end date
2018-11-30
UEI
K2M9T6LVC4H9
Solicitation number
ES16-012
Topic code
NIEHS

Research abstract

Summary Methods to preserve and store biomolecules and the tissues that contain them are essential to molecular characterization of disease and associated lesions The long used standard method for preserving such samples is formalin fixation While this approach does preserve tissue morphology for microscopic examination it creates extensive and complex adducts with the nucleic acids and proteins For modern molecular analysis these adducts interfere and must be removed Unfortunately harsh conditions are required causing further damage and hindering recovery Here we propose to develop an entirely new fully reversible chemistry for biomolecule and tissue fixation that overcomes these problems The approach is based on reversible acylation REAC chemistry using specialized water soluble cell permeable acylimidazole reagents to react with important functional groups of nucleic acids proteins and carbohydrates These adducts are expected to stabilize and crosslink the biomolecules indefinitely and preserve tissue morphology When molecular analysis is desired the acyl groups can be removed virtually completely by addition of a second cell permeable reagent a soluble phosphine under exceptionally mild conditions restoring the molecular integrity of the biomolecules to their native states for analysis via amplification sequencing IHC or mass spectrometry The hypotheses driving this research are that REAC agents can provide general protection of biomolecules and tissue from biological degradation during fixation and storage and that the resulting adducts can be reversed in high yields to reveal native biomolecules with better integrity than formalin fixation The preliminary studies have shown that the prototype NAI reversible reagent can acylate both RNAs and proteins in high yields Importantly the groups can be removed with a water soluble phosphine at room temperature in high yields restoring the native undisturbed biomolecules This project is innovative because it introduces an entirely new molecular strategy for fixation and stabilization of biomolecules Both the molecules and methods described here are unknown in the literature The work is significant because high resolution molecular characterization and quantification of biomolecules is becoming a requirement for accurate analysis of disease and lesions However formalin fixation is universally recognized as a poor choice for preserving such samples If successful our approach will solve the problems of the complex and irreversible damage caused during and after formalin fixation The new REAC method can be easily applied by non chemists and will yield the highest quality biomolecules in their native forms Narrative Relevance Our proposed research is aimed at developing new chemical strategies for stabilizing and preserving biomolecules in human tissue and blood samples It is expected to greatly improve the quality of RNA DNA proteins and carbohydrates obtained from these stored tissues enabling high precision and quantitative molecular analysis for biology and medicine We expect that this new technology can replace the current method of fixing tissues with formalin which damages biomolecules in the sample

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2015–2017). Reported award amounts total $1,871,031. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.